Docking Studies of Structurally Diverse Antimalarial Drugs Targeting PfATP6: No Correlation between in silico Binding Affinity and in vitro Antimalarial Activity.

PfATP6, a calcium‐dependent ATPase of Plasmodium falciparum, is considered the putative target of the antimalarial drug artemisinin and its derivatives. Herein, the 3D structure of PfATP6 was modeled on the basis of the crystal structure of SERCA 1a, the mammalian homologue. Model validation was achieved using protein structure checking tools. AutoDock4 was used to predict the binding affinities of artemisinin (and analogues) and various other antimalarial agents for PfATP6, for which in vitro activity is also reported. No correlation was found between the affinity of the compounds for PfATP6 predicted by AutoDock4 and their antimalarial activity.

[1]  Nuna C. P. Araújo,et al.  Semi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates. , 2009, Bioorganic & medicinal chemistry letters.

[2]  B. Mordmüller,et al.  Selection of a trioxaquine as an antimalarial drug candidate , 2008, Proceedings of the National Academy of Sciences.

[3]  B. Meunier,et al.  The Antimalarial Trioxaquine DU1301 Alkylates Heme in Malaria-Infected Mice , 2008, Antimicrobial Agents and Chemotherapy.

[4]  K. Rieckmann,et al.  First Assessment in Humans of the Safety, Tolerability, Pharmacokinetics, and Ex Vivo Pharmacodynamic Antimalarial Activity of the New Artemisinin Derivative Artemisone , 2008, Antimicrobial Agents and Chemotherapy.

[5]  B. Meunier,et al.  The Antimalarial Artemisone is an Efficient Heme Alkylating Agent , 2008 .

[6]  S. Meshnick,et al.  Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border , 2008, Emerging infectious diseases.

[7]  N. White,et al.  Qinghaosu (Artemisinin): The Price of Success , 2008, Science.

[8]  Peter D Gibbons,et al.  Two-step synthesis of achiral dispiro-1,2,4,5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profiles. , 2008, Journal of medicinal chemistry.

[9]  R. Prankerd,et al.  Relationship between Antimalarial Activity and Heme Alkylation for Spiro- and Dispiro-1,2,4-Trioxolane Antimalarials , 2008, Antimicrobial Agents and Chemotherapy.

[10]  B. Meunier,et al.  Hybrid molecules with a dual mode of action: dream or reality? , 2008, Accounts of chemical research.

[11]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[12]  J. Chollet,et al.  Spiro- and dispiro-1,2-dioxolanes: contribution of iron(II)-mediated one-electron vs two-electron reduction to the activity of antimalarial peroxides. , 2007, Journal of medicinal chemistry.

[13]  Dennis K. Taylor,et al.  Artemisinin and a Series of Novel Endoperoxide Antimalarials Exert Early Effects on Digestive Vacuole Morphology , 2007, Antimicrobial Agents and Chemotherapy.

[14]  S. Parapini,et al.  The Fe2+‐Mediated Decomposition, PfATP6 Binding, and Antimalarial Activities of Artemisone and Other Artemisinins: The Unlikelihood of C‐Centered Radicals as Bioactive Intermediates , 2007, ChemMedChem.

[15]  J. Stewart.  Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements , 2007, Journal of molecular modeling.

[16]  J. Lelièvre,et al.  Trioxaquines and Heme-Artemisinin Adducts Inhibit the In Vitro Formation of Hemozoin Better than Chloroquine , 2007, Antimicrobial Agents and Chemotherapy.

[17]  R. Brun,et al.  Peroxide Bond-Dependent Antiplasmodial Specificity of Artemisinin and OZ277 (RBx11160) , 2007, Antimicrobial Agents and Chemotherapy.

[18]  David S. Goodsell,et al.  A semiempirical free energy force field with charge‐based desolvation , 2007, J. Comput. Chem..

[19]  K. Moncoq,et al.  The Molecular Basis for Cyclopiazonic Acid Inhibition of the Sarcoplasmic Reticulum Calcium Pump* , 2007, Journal of Biological Chemistry.

[20]  J. Lelièvre,et al.  Trioxaquines Are New Antimalarial Agents Active on All Erythrocytic Forms, Including Gametocytes , 2007, Antimicrobial Agents and Chemotherapy.

[21]  S. Krishna,et al.  Mechanism of Antimalarial Action of the Synthetic Trioxolane RBX11160 (OZ277) , 2006, Antimicrobial Agents and Chemotherapy.

[22]  R. Amewu,et al.  Design and synthesis of orally active dispiro 1,2,4,5-tetraoxanes; synthetic antimalarials with superior activity to artemisinin. , 2006, Organic & biomolecular chemistry.

[23]  S. Croft,et al.  Cover Picture: Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class (Angew. Chem. Int. Ed. 13/2006) , 2006 .

[24]  S. Croft,et al.  Titelbild: Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class (Angew. Chem. 13/2006) , 2006 .

[25]  A. C. Alves,et al.  Malaria Parasites Can Develop Stable Resistance to Artemisinin but Lack Mutations in Candidate Genes atp6 (Encoding the Sarcoplasmic and Endoplasmic Reticulum Ca2+ ATPase), tctp, mdr1, and cg10 , 2006, Antimicrobial Agents and Chemotherapy.

[26]  Eric Legrand,et al.  Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6 , 2005, The Lancet.

[27]  B. Meunier,et al.  The antimalarial drug artemisinin alkylates heme in infected mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. No,et al.  Three-dimensional structure of Plasmodium falciparum Ca2+ -ATPase(PfATP6) and docking of artemisinin derivatives to PfATP6. , 2005, Bioorganic & medicinal chemistry letters.

[29]  Angus Cameron,et al.  A single amino acid residue can determine the sensitivity of SERCAs to artemisinins , 2005, Nature Structural &Molecular Biology.

[30]  C. Jaxel,et al.  Fe2+-catalyzed Oxidative Cleavages of Ca2+-ATPase Reveal Novel Features of Its Pumping Mechanism* , 2004, Journal of Biological Chemistry.

[31]  Christian Scheurer,et al.  Identification of an antimalarial synthetic trioxolane drug development candidate , 2004, Nature.

[32]  S. Paula,et al.  Molecular determinants of thapsigargin binding by SERCA Ca2+‐ATPase: A computational docking study , 2004, Proteins.

[33]  C. Toyoshima,et al.  Crystal structure of the calcium pump with a bound ATP analogue , 2004, Nature.

[34]  H. Vial,et al.  Synthesis and antimalarial activity of trioxaquine derivatives. , 2004, Chemistry.

[35]  S. Krishna,et al.  Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.

[36]  Hiromi Nomura,et al.  Structural changes in the calcium pump accompanying the dissociation of calcium , 2002, Nature.

[37]  Alessandro Pedretti,et al.  VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. , 2002, Journal of molecular graphics & modelling.

[38]  B. Meunier,et al.  From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. , 2002, Accounts of chemical research.

[39]  C. Hentschel.  The Medicines for Malaria Venture , 2002, Nature.

[40]  G. Sachs,et al.  Selective Fe2+-catalyzed Oxidative Cleavage of Gastric H+,K+-ATPase , 2001, The Journal of Biological Chemistry.

[41]  B. Meunier,et al.  Characterization of the Alkylation Product of Heme by the Antimalarial Drug Artemisinin , 2001 .

[42]  K. Nakanishi,et al.  Biological implication of conformational flexibility in ouabain: observations with two ouabain phosphate isomers. , 2001, Biochemistry.

[43]  B. Meunier,et al.  Preparation and Antimalarial Activities of “Trioxaquines”, New Modular Molecules with a Trioxane Skeleton Linked to a 4‐Aminoquinoline , 2000, Chembiochem : a European journal of chemical biology.

[44]  A. Sali,et al.  Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.

[45]  R. Snow,et al.  Averting a malaria disaster , 1999, The Lancet.

[46]  D. Goldberg,et al.  A Common Mechanism for Blockade of Heme Polymerization by Antimalarial Quinolines* , 1998, The Journal of Biological Chemistry.

[47]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[48]  B. Meunier,et al.  Characterization of the First Covalent Adduct between Artemisinin and a Heme Model , 1997 .

[49]  D. Sullivan,et al.  On the molecular mechanism of chloroquine's antimalarial action. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[50]  U. Burger,et al.  The Deoxygenation and Isomerization of Artemisinin and Artemether and Their Relevance to Antimalarial Action , 1996 .

[51]  S. Meshnick,et al.  Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. , 1996, Microbiological reviews.

[52]  C. W. Jefford,et al.  The Decomposition of cis‐Fused Cyclopenteno‐1,2,4‐Trioxanes induced by Ferrous Salts and some oxophilic reagents , 1995 .

[53]  S. Meshnick,et al.  Reaction of antimalarial endoperoxides with specific parasite proteins , 1994, Antimicrobial Agents and Chemotherapy.

[54]  L. Gerena,et al.  Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity. , 1994, Journal of medicinal chemistry.

[55]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[56]  Robert W. Harrison,et al.  Stiffness and energy conservation in molecular dynamics: An improved integrator , 1993, J. Comput. Chem..

[57]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[58]  J. Thornton,et al.  Stereochemical quality of protein structure coordinates , 1992, Proteins.

[59]  S. Meshnick,et al.  Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. , 1991, Molecular and biochemical parasitology.

[60]  J. Lytton,et al.  Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. , 1991, The Journal of biological chemistry.

[61]  Y. Sagara,et al.  Inhibition of the sarcoplasmic reticulum Ca2+ transport ATPase by thapsigargin at subnanomolar concentrations. , 1991, The Journal of biological chemistry.

[62]  P. Cullen,et al.  Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Arup K. Ghose,et al.  Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics , 1989, J. Chem. Inf. Comput. Sci..

[64]  D. L. Klayman,et al.  Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 2. Stereospecificity of the ether side chain. , 1989, Journal of medicinal chemistry.

[65]  D. Ofori-Adjei,et al.  [In vitro activity of chloroquine, two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum]. , 1986, Ji sheng chong xue yu ji sheng chong bing za zhi = Journal of parasitology & parasitic diseases.

[66]  D. L. Klayman,et al.  Qinghaosu (artemisinin): an antimalarial drug from China , 1985 .

[67]  J. Haynes,et al.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique , 1979, Antimicrobial Agents and Chemotherapy.

[68]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.